Aquestive Therapeutics, Inc. (AQST)
USD 3.0
(0.0%)
USD 3.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 98.82 Million USD | 76.18% |
| 2022 | 56.09 Million USD | -0.58% |
| 2021 | 56.42 Million USD | 39.39% |
| 2020 | 40.47 Million USD | -32.91% |
| 2019 | 60.33 Million USD | 27.83% |
| 2018 | 47.2 Million USD | 3.73% |
| 2017 | 45.5 Million USD | 17.74% |
| 2016 | 38.65 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 115.13 Million USD | 16.51% |
| 2024 Q2 | 116.88 Million USD | 1.52% |
| 2024 Q3 | 36.86 Million USD | -68.46% |
| 2023 Q3 | 45.03 Million USD | -0.18% |
| 2023 Q4 | 98.82 Million USD | 119.42% |
| 2023 FY | 98.82 Million USD | 76.18% |
| 2023 Q1 | 48.42 Million USD | -13.67% |
| 2023 Q2 | 45.12 Million USD | -6.82% |
| 2022 Q4 | 56.09 Million USD | 1.83% |
| 2022 Q3 | 55.08 Million USD | -1.61% |
| 2022 Q2 | 55.98 Million USD | -1.57% |
| 2022 FY | 56.09 Million USD | -0.58% |
| 2022 Q1 | 56.87 Million USD | 0.81% |
| 2021 Q4 | 56.42 Million USD | 29.87% |
| 2021 Q2 | 42.45 Million USD | 2.36% |
| 2021 Q3 | 43.44 Million USD | 2.32% |
| 2021 FY | 56.42 Million USD | 39.39% |
| 2021 Q1 | 41.47 Million USD | 2.47% |
| 2020 Q1 | 64.95 Million USD | 7.65% |
| 2020 FY | 40.47 Million USD | -32.91% |
| 2020 Q4 | 40.47 Million USD | -38.49% |
| 2020 Q3 | 65.8 Million USD | 0.57% |
| 2020 Q2 | 65.43 Million USD | 0.74% |
| 2019 Q4 | 60.33 Million USD | 0.94% |
| 2019 Q3 | 59.77 Million USD | 26.02% |
| 2019 Q2 | 47.43 Million USD | -0.33% |
| 2019 Q1 | 47.59 Million USD | 0.82% |
| 2019 FY | 60.33 Million USD | 27.83% |
| 2018 Q1 | 45.96 Million USD | 1.01% |
| 2018 FY | 47.2 Million USD | 3.73% |
| 2018 Q3 | 46.8 Million USD | 0.81% |
| 2018 Q4 | 47.2 Million USD | 0.85% |
| 2018 Q2 | 46.43 Million USD | 1.01% |
| 2017 FY | 45.5 Million USD | 17.74% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 45.5 Million USD | 0.0% |
| 2016 FY | 38.65 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Theratechnologies Inc. | 58.96 Million USD | -67.586% |
| Safety Shot Inc | 1.54 Million USD | -6279.836% |
| Biofrontera Inc. | 5.39 Million USD | -1730.376% |
| DURECT Corporation | 20.74 Million USD | -376.342% |
| Cosmos Health Inc. | 12.42 Million USD | -695.415% |
| Cronos Group Inc. | 2.53 Million USD | -3790.725% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | 81.732% |
| Ironwood Pharmaceuticals, Inc. | 715.53 Million USD | 86.189% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | -172.065% |
| RedHill Biopharma Ltd. | 1.17 Million USD | -8324.68% |
| Organogenesis Holdings Inc. | 119.35 Million USD | 17.201% |
| Universe Pharmaceuticals INC | 5.48 Million USD | -1702.513% |
| ProPhase Labs, Inc. | 21.38 Million USD | -362.217% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -14925.277% |
| Alpha Teknova, Inc. | 30.45 Million USD | -224.453% |
| Intra-Cellular Therapies, Inc. | 16.93 Million USD | -483.434% |
| SCYNEXIS, Inc. | 15.08 Million USD | -555.318% |
| ANI Pharmaceuticals, Inc. | 315.32 Million USD | 68.661% |
| Sonoma Pharmaceuticals, Inc. | 608 Thousand USD | -16153.618% |
| Dynavax Technologies Corporation | 256.91 Million USD | 61.535% |
| SIGA Technologies, Inc. | 1.46 Million USD | -6650.095% |
| Lifecore Biomedical, Inc. | 130.36 Million USD | 24.193% |
| Shineco, Inc. | 29.65 Million USD | -233.223% |
| Indivior PLC | 281.6 Million USD | 64.907% |
| Regencell Bioscience Holdings Limited | 59.8 Thousand USD | -165134.839% |
| Radius Health, Inc. | 365.31 Million USD | 72.949% |
| Sunshine Biopharma, Inc. | 657.7 Thousand USD | -14925.277% |
| Incannex Healthcare Limited | 373 Thousand USD | -26393.834% |
| China SXT Pharmaceuticals, Inc. | 2.64 Million USD | -3632.717% |
| Alimera Sciences, Inc. | 67.39 Million USD | -46.622% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Shuttle Pharmaceuticals Holdings, Inc. | 1.08 Million USD | -8985.46% |
| Alvotech | 1.07 Billion USD | 90.811% |
| Journey Medical Corporation | 17.73 Million USD | -457.372% |
| Petros Pharmaceuticals, Inc. | 8.27 Million USD | -1093.994% |
| Embecta Corp. | 1.63 Billion USD | 93.969% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -9465.44% |
| Procaps Group, S.A. | 285.93 Million USD | 65.439% |
| PainReform Ltd. | 86 Thousand USD | -114809.302% |
| Harrow Health, Inc. | 190.5 Million USD | 48.125% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -137.97% |
| OptiNose, Inc. | 131.74 Million USD | 24.992% |
| Kamada Ltd. | 8.74 Million USD | -1029.525% |
| Cumberland Pharmaceuticals Inc. | 18.42 Million USD | -436.246% |
| Phibro Animal Health Corporation | 525.45 Million USD | 81.193% |
| Procaps Group S.A. | 285.93 Million USD | 65.439% |
| TherapeuticsMD, Inc. | 8 Million USD | -1134.503% |
| Talphera, Inc. | - USD | -Infinity% |
| Viatris Inc. | 18.12 Billion USD | 99.455% |
| Rockwell Medical, Inc. | 13.43 Million USD | -635.337% |
| Aytu BioPharma, Inc. | 15.12 Million USD | -553.196% |
| Tilray Brands, Inc. | 387.31 Million USD | 74.485% |
| Collegium Pharmaceutical, Inc. | 674.28 Million USD | 85.344% |
| PetIQ, Inc. | 468.3 Million USD | 78.898% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | 76.932% |
| Assertio Holdings, Inc. | 40.91 Million USD | -141.548% |
| Lantheus Holdings, Inc. | 616.94 Million USD | 83.982% |
| Avadel Pharmaceuticals plc | 35.38 Million USD | -179.284% |
| Hempacco Co., Inc. | 13.72 Million USD | -620.041% |
| Pacira BioSciences, Inc. | 586.04 Million USD | 83.137% |
| Alvotech | 1.07 Billion USD | 90.811% |
| Currenc Group, Inc. | 31.94 Million USD | -209.364% |
| Evoke Pharma, Inc. | 5 Million USD | -1876.44% |
| Flora Growth Corp. | 3.67 Million USD | -2591.231% |
| Cyclo Therapeutics, Inc. | 1.03 Million USD | -9465.44% |
| Evolus, Inc. | 126.54 Million USD | 21.908% |
| HUTCHMED (China) Limited | 86.13 Million USD | -14.735% |
| Amphastar Pharmaceuticals, Inc. | 623.64 Million USD | 84.154% |
| Akanda Corp. | 3.99 Million USD | -2371.297% |